Our office will be close at midday on Friday 23 December 2022 and reopen on Monday 9 January 2023. If you would like our staff to contact you when we return please leave a phone message or email us on email@example.com. Merry Christmas!
A new imaging tool means that scientists can now directly measure the levels of the toxic huntingtin protein in animal models of Huntington’s disease. HD Buzz explain
Due to the current weather emergency in South East Queensland our staff will not be in the office for the next few days. We are of course available via phone or email, so please leave a message and we will contact you as soon as possible. Stay safe everyone!
Researchers at Edith Cowan University are undertaking a research study investigating health literacy and ehealth literacy in individuals living with neurological conditions and caregivers. The information gathered from this study will help to understand whether health information is being communicated appropriately for people living with neurological conditions. If you would like to participate please visit […]
HD Buzz share some exciting new findings – a promising new huntingtin lowering drug that can be taken as a pill.
We are pleased to share the link to the recent Roche community presentation of tominersen data and planned trail as mentioned in previous posts and emails.
Due to the current Omicron Covid outbreak, we are suspending all ‘in person’ Support groups during February for the safety of our clients and staff. We hope to resume again in March. Our staff are of course still available if you need support or have questions. We will also be holding an extra ZOOM chat […]
HD Buzz explain the update on the Roche trial data and upcoming Phase II trail
Following the disappointing news in March last year that Roche’s highly anticipated drug trial for the HD drug tominersen would be abandoned, we’ve had a more promising start to 2022! Roche has just announced that they will be starting a new Phase II clinical trial into the drug, which they say appears to have some […]
We are pleased to share the outcomes from the Stout Labs 2021 research update.